Nga Kaiwhakawaenga Waenganui AF
| mo te API | CAS KORE. |
| Aceclofenac | 139272-68-7 |
| Adapalene | 33626-98-1 |
| 104224-63-7 | |
| Aprepitant | 155742-64-6 |
| 171482-05-6 | |
| Aripiprazole | 119532-26-2 |
| 129722-34-5 | |
| 22246-18-0 | |
| Atorvastatin | 125971-95-1 |
| Azathioprine | 50-44-2 |
| 4897-25-0 | |
| Azithromycin | 76801-85-9 |
| Bosentan | 138588-40-6 |
| 150728-12-4 | |
| 150728-13-5 | |
| Capecitabine | 161599-46-8 |
| 62211-93-2 | |
| Cinacalcet | 134002-26-9 |
| 21172-41-8 | |
| Koprofloxacin | 86393-33-1 |
| Clavulanate Potassium | 61177-45-5 |
| Clopidogrel | 141109-18-4 |
| Cobicistat | 154212-60-9 |
| 1185167-55-8 | |
| Darunavir | 169280-56-2 |
| 866594-60-7 | |
| 253265-97-3 | |
| Te Sodium Diclofenac | 15362-40-0 |
| Dolutegravir | 61477-40-5 |
| 1299006-34-1 | |
| 1229006-35-2 | |
| 1335210-23-5 | |
| 1335210-35-9 | |
| Efavirenz | 173676-59-0 |
| 209414-27-7 | |
| Empagliflozin | 915095-99-7 |
| Entecavir | 110567-22-1 |
| 142217-81-0 | |
| 204845-95-4 | |
| Etoricoxib | 3446-89-7 |
| Etravirinem | 4198-90-7 |
| Febuxostat | 161797-99-5 |
| Ingoa hua | Ingoakapa | Tātai rāpoi | Taumaha Molecular | PSA | Takiuru | Tau MDL | Te Ahua me te Whenua Tinana | Taumaha | Tohu Whewhe | Tohu rewa | Tohu Hiko | Tohu Whakaoho | Te Pakaranga Ngawha | HS Waehere |
| 2- (tert-butoxy) -2-oxoethyl 2- (2 - ((2,6-dichlorophenyl) amino) phenyl) acetate | ACECLOFENAC TERT-BUTYL ESTER; Aceclofenac Tert-Butyl Ester; | C20H21Cl2NO4 | 410.291 | 64.63 | 5.2374 | |||||||||
| methyl 6-bromonaphthalene-2-carboxylate | 6-Bromo-2-naphthalenecarboxylic Acid Methyl Ester; methyl 6-bromo-2-naphthoate; methyl 6-bromo-2-naphthalenecarboxylate; 6-bromonaphthalene-2-carboxylic acid methyl ester; 6-bromo-2-naphthoic acid methyl ester ; methyl-6-bromonaphtoate; | C12H9BrO2 | 265.103 | 26.3 | 3.3889 | MFCD00100408 | Paura Koura Koura | 1.492 g / cm3 | 357ºC i te 760 mmHg | 123-126ºC | 169.7ºC | 1.634 | 2916399090 | |
| 2- (1-Adamantyl) -4-bromoanisole | 1- (5-bromo-2-methoxyphenyl) adamantane; 1- (5-Bromo-2-methoxy-phenyl) adamantane; | C17H21BrO | 321.252 | 9.23 | 4.9255 | MFCD03855308 | 1.346g / cm3 | 402.5ºC i te 760mmHg | 160.3ºC | 1.593 | 2.54E-06mmHg i te 25 ° C | 2909309090 | ||
| Methyl 2- (2-chloro-1-iminoethyl) hydrazinecarboxylate | N-Methylcarbonyl-2-chloroacetamidrazone; | C4H8ClN3O2 | 165.578 | 74.21 | 0.9446 | MFCD09840880 | 2928000090 | |||||||
| (2R, 3S) -2 - ((R) -1- (3,5-Bis (trifluoromethyl) phenyl) ethoxy) -3- (4-fluorophenyl) morpholine hydrochloride | (2R, 3S) -2 - ((R) -1- (3,5-Bis (trifluoromethyl) phenyl) ethoxy) -3- (4-fluorophenyl) morpholine hydrochloride | C20H18F7NO2.HCl | 473.812 | 30.49 | 6.7589 | 387.9ºC i te 760 mmHg | 188.4ºC | |||||||
| 1- (2,3-Dichlorophenyl) piperazine hydrochloride | RARECHEM AH CK 0082; 1- (2,3-Dichlorophenyl) piperazine Hydrochloride; DCPP-Hydrochloride; | C10H12Cl2N2.HCl | 267.583 | 15.27 | 3.5988 | MFCD00190238 | Tuatea-Maama | 1.272g / cm3 | 365.1ºC i te 760mmHg | 245-247ºC | 208.2ºC | 1.77E-07mmHg i te 25 ° C | 2933599090 | |
| 3,4-Dihydro-7- (4-bromobutoxy) -2 (1H) -quinolinone | 7- (4-BroMobutoxy) -3,4-dihydro-2 (1H) -quinolinone; 7- (4-Bromobutoxy) -1,2,3,4-tetrahydro-2-oxoquinoline; 7- (4-bromobutoxy) -3,4-dihydro-1H-quinolin-2-one; 7- (4-Bromobutoxy) -3,4-dihydroquinolin-2 (1H)-kotahi; | C13H16BrNO2 | 298.176 | 38.33 | 3.2632 | MFCD06658540 | 1.383 g / cm3 | 463.4ºC i te 760 mmHg | 110-111ºC | 234.1ºC | 1.573 | 2.45E-08mmHg i te 25 ° C | 2942000000 | |
| 7-hydroxy-3,4-dihydro-1H-quinolin-2-one | 3,4-Dihydro-7-hydroxycarbostyril; 7-Hydroxy-3,4-dihydroquinolin-2 (1H) -one; 7-Hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline; 7-Hydroxy-3 , 4-dihydro-2 (1H) -quinolinone; 7-Hydroxy-3,4-dihydro-quinolin-2-one; 7-hydroxy-3,4-dihydro-2-quinolinone; 7-Hydroxy-3,4- dihydro carbostyril; 3,4-Dihydro-7-hydroxy-2 (1H) -quinolinone; | C9H9NO2 | 163.173 | 49.33 | 1.4149 | MFCD06410891 | Paura ma | 1.282 g / cm3 | 403.7ºC i te 760 mmHg | 233-237ºC | 198ºC | 2933499090 | ||
| tert-Butyl (4R, 6R) -2 - [[[6- (2-4-fluorophenyl) -5-isopropyl-3-phenyl-4- (phenylcarbamoyl) pyrrol-1-yl] ethyl] -2,2- dimethyl-1,3-dioxan-4-yl] acetate | Atorvastatin Acetonide tert-Butyl Ester; Atorvastatin takawaenga L1; Atorvastatin calciuM interMediate; | C40H47FN2O5 | 654.81 | 78.79 | 9.442 | 1.15 g / cm3 | 678.035ºC i te 760 mmHg | 144-148ºC | 363.863ºC | 1.589 | 0mmHg i te 25 ° C | |||
| merc laptopurine | 1H-Purine-6 (9H) -thione; 6-Merc Laptopurine; 6H-Purine-6-thione, 1,7-dihydro-; 1,9-Dihydropurine-6-thione KAUPAPA, tirohia M225450; | C5H4N4S | 152.177 | 89.45 | 1.0155 | puehu karaehe kowhai | 1.82g / cm3 | > 313ºC | 255.4ºC | 1.828 | 2933599090 | |||
| 5-Chloro-1-methyl-4-nitroimidazole | 5-Chloro-1-Methyl-4-Nitroimidazole; PCMNI; 1-methyl-4-nitro-5-chloroimidazole; 5-chloro-1-methyl-4-nitro-imidazole; 5-Chloro-1-methyl-4- nitro-1H-imidazole; 1-Methyl-5-chloro-4-nitroimidazole; Imidazole, 5-chloro-1-methyl-4-nitro; EINECS 225-521-2; 1H-Imidazole, 5-chloro-1-methyl -4-nitro; | C4H4ClN3O2 | 161.546 | 63.64 | 1.5049 | MFCD00233664 | Maamaa | 1.65 g / cm3 | 362.3ºC i te 760 mmHg | 146-150ºC | 172.9ºC | 1.648 | 2933290090 | |
| Azathramycin | 9-deokso-9a-aza-9a-homoeritromicin A; Desmethylazithromycin; 9a-N-desmethyl azithromycin; DD-Azaerythromycin A; 10-Dihydro-10-deoxo-11-azaerythromycin A; 9-Deoxo-9a-aza-9a- homo Erythromycin A (Desmethyl Azithromycin); 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin A; 9a-aza-9-deoxo-9a-homoerythromycin A; 9-deoxo-9a-aza-9a-homoerythromycin Azaerythromycin A; UNII-4LSP9FJT5B; 9-deoxo-9a-aza-9a-homoerythromycin A; Azathramycin; | C37H70N2O12 | 734.958 | 188.87 | 1.8873 | Maamaa | 1.18 | 815.2ºC i te 760 mmHg | 126-136ºC | 446.8ºC | 1.536 | |||
| 2-Amidinopyrimidine Hydrochloride | 2-Amidinopyrimidine hydrochloride; pyrimidine-2-carboximidamide, hydrochloride; | C5H6N4.HCl | 158.589 | 158.589 | 1.3627 | MFCD02677965 | puehu ma-ma | 1.39 g / cm3 | 287.4ºC i te 760 mmHg | 180-183ºC (Tuwhena) | 127.6ºC | 1.68 | 0.002mmHg i te 25 ° C | 2933599090 |
| 5- (2-Methoxyphenoxy) - [2,2-Bipyrimidine] -4,6 (1H, 5H) -Dione | 5- (2-Methoxyphenoxy) - [2,2'-bipyrimidine] -4,6 (1H, 5H) -dione; 5- (2-Methoxyphenoxy) - [2,2'-bipyrimidine] -4,6 [1H , 5H] -mioni; | C15H12N4O4 | 312.28 | 102.77 | 0.1002 | MFCD09879703 | 1.45 | 1.676 | 2933599090 | |||||
| 4,6-Dichloro-5- (2-Methoxyphenoxy) -2,2-Bipyrimidine | 4,6-Dichloro-5- (2-methoxyphenoxy) -2,2'-bipyrimidine; 4,6-Dichloro-5- (2-methoxyphenoxy) -2,2'-bipyrimidine; 4,6-Dichloro-5- (O-methoxyphenoxy) -2- (2-pyrimidinyl) pyrimidine; 4,6-Dichloro-5- (2-methoxyphenoxy) -2,2-bipyrimidine; | C15H10Cl2N4O2 | 349.172 | 70.02 | 4.0413 | MFCD03839838 | Parauri totoka | 1.418 g / cm3 | 520.7ºC i te 760 mmHg | 268.7ºC | 1.617 | 0mmHg i te 25 ° C | 2933599090 | |
| 2 ', 3'-di-O-acetyl-5'-deoxy-5-fluorocytidine | 5'-Deoxy-2 ', 3'-di-O-acetyl-5-fluorocytidine; [(2R, 3R, 4R, 5R) -4-acetyloxy-5- (4-amino-5-fluoro-2-oxopyrimidin -1-yl) -2-methyloxolan-3-yl] acetate; 2,3-Di-O-Acetyl-5-Deoxy-5-Fuluro-D-Cytidine; 2 ', 3'-di-O-acetyl- 5'-deoxy-5-fulurocytidine; | C13H16FN3O6 | 329.281 | 122.74 | 0.3265 | MFCD07369302 | 2934999090 | |||||||
| 1,2,3-Triacetyl-5-deoxy-D-ribose | 1,2,3-Triacetyl-5-de; 1,2,3-triacetoxy-5-deoxy-D-ribose; Capecitabine takawaenga; 5-Deoxy-bD-ribofuranose triacetate; ACETYLFURANOSIDE; 5-Deoxy-bD-ribofuranose; 1,2,3-Triacetoxy-5-Deoxy Ribose; | C11H16O7 | 260.241 | 88.13 | 0.1577 | MFCD11519026 | 1.23 | 315ºC | 63-64ºC | 136ºC | 1.465 | 2940000000 | ||
| (S) -2,2-Diphenyl-2- (pyrrolidin-3-yl) acetamide (2R, 3R) -2,3-dihydroxysuccinate | (2R, 3R) -2,3-dihydroxybutanedioic waikawa, 2,2-diphenyl-2 - [(3S) -pyrrolidin-3-yl] acetamide; | C18H20N2O.C4H6O6 | 430.451 | 170.18 | 0.974 | Paura ma | ||||||||
| 3- [3- (trifluoromethyl) phenyl] whakatipuranga | 3- (3-Trifluoromethylphenyl) propionaldehyde | C10H9F3O | 202.173 | 17.07 | 2.8369 | te hinu karakara | 1.192 g / cm3 | 207.4ºC i te 760 mmHg | 93.1ºC | 2913000090 | ||||
| 7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid | 7-chloro-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid; | C13H9ClFNO3 | 281.667 | 59.3 | 2.8271 | MFCD00792458 | puehu tioata ma-ma | 410ºC | 239-244ºC | 236.4ºC | 2933499090 | |||
| Clavulanate pāhare pāporo | Pāhare pāporo (Z) - (2R, 5R) -3- (2-hydroxyethylidene) -7-oxo-4-oxa-1-azabicyclo [3.2.0] heptane-2-carboxylate | C8H8KNO5 | 237.251 | 89.9 | -2.4924 | MFCD01710901 | Pale Kōwhai totoka | 545.8ºC i te 760 mmHg | > 160ºC | 283.9ºC | 2942000000 | |||
| (+) METHYL α- (2-THIENYLETHYLAMINO) (2-CHLOROPHENYL) ACETATE HCL | Methyl 2- (2-chlorophenyl) -2 - ((2- (thiophen-2-yl) ethyl) aMino) acetate hydrochloride; METHYL A - [[2- (THIEN-2-YL) ETHYL] AMINO] -A- (2-CHLOROPHENYL) ACETATE HYDROCHLORIDE; | C15H17Cl2NO2S | 346.272 | 66.57 | 4.6408 | 444ºC i te 760 mmHg | 222.4ºC | 2.73E-08mmHg i te 25 ° C | ||||||
| N-methyl-1- (2-propan-2-yl-1,3-thiazol-4-yl) methanamine | 1- (2-Isopropylthiazol-4-yl) -N-methyl methanamine | C8H14N2S | 170.275 | 53.16 | 2.3768 | 1.039g / cm3 | 230.874ºC i te 760 mmHg | 93.429ºC | 1.523 | 0.064mmHg i te 25 ° C | 2934100090 | |||
| 1- (2-Isopropyl-1,3-thiazol-4-yl) -N-methylmethanamine dihydrochlor ide | N-Methyl-2- (1-methylethyl) -4-thiazolemethanamine dihydrochloride | C8H14N2S.2 (HCl) | 243.197 | 53.16 | 3.9808 | 2934100090 | ||||||||
| 4-amino-N - [(2R, 3S) -3-amino-2-hydroxy-4-phenylbutyl] -N- (2-methylpropyl) benzenesulfonamide | C20H29N3O3S | 391.528 | 118.03 | 4.2087 | 1.226 g / cm3 | 609.105ºC i te 760 mmHg | 322.175ºC | 1.605 | ||||||
| (3aS, 4S, 6aR) -4-methoxy-tetrahydro-furo [3.4-b] furan-2 (3H)-kotahi | (3aS, 4S, 6aR) -4-Methoxytetrahydrofuro [3,4-b] furan-2 (3H)-Kotahi; (3aS, 4S, 6aR) - 4-methoxytetrahydrofuro [3,4-b] furan-2 ( 3H) -one; FURO [3,4-B] FURAN-2 (3H) -ONE, TETRAHYDRO-4-METHOXY-, (3AS, 4S, 6AR) -; (3aS, 4S, 6aR) -Tetrahydro-4- methoxyfuro [3,4-b] furan-2 (3H)-kotahi; | C7H10O4 | 158.152 | 44.76 | -0.0792 | |||||||||
| [(3R, 3aS, 6aR) -Hydroxyhexahydrofuro [2,3-b] furanyl Succinimidyl Carbonate | (3R, 3aS, 6aR) -Hydroxyhexahydrofuro [2,3-β] furanyl Succinimidyl Carbonate; | C11H13NO7 | 271.223 | 91.37 | -0.0971 | 1.51 g / cm3 | 391.8ºC i te 760 mmHg | 190.7ºC | 1.562 | 2.41E-06mmHg i te 25 ° C | ||||
| 1- (2,6-Dichlorophenyl) Indolin-2-Kotahi | 1- (2,6-Dichlorophenyl) -1,3-dihydro-2H-indol-2-one; Diclofenac Amide; (N- (2,6-Dichlorophenyl) -2-indolinone; 1- (2,6-Dichlorophenyl ) indolin-2-one; 1- (2,6-Dichlorophenyl) -2-oxoindoline; 1- (2,6-Dichlorophenyl) -2-indolinone; 1- (2,6-Dichlorophenyl) oxindole; 1- (2 , 6-dichlorophenyl) -3H-indol-2-one; Diclofenac poke A; N- (2,6-Dichlorophenyl) -2-indolinone; | C14H9Cl2NO | 278.133 | 20.31 | 4.2792 | MFCD00451393 | 1.432 g / cm3 | 488.6ºC i te 760 mmHg | 249.3ºC | 2933790090 | ||||
| (R) -3-Aminobutan-1-ol | (3R) -3-aminobutan-1-ol; | C4H11NO | 89.1362 | 46.25 | 0.4163 | 640-387-9 | 168.349ºC i te 760 mmHg | 55.616ºC | 2922199090 | |||||
| 2H-Pyrido [1 ', 2'; 4,5] pyrazino [2,1-b] [1,3] oxazine-6,8-dione, 3,4,12,12a-tetrahydro-7- (phenylmethoxy) | ||||||||||||||
| 7- (benzyloxy) -9-bromo-3,4,12,12a-tetrahydro-2H-pyrido [1 ', 2': 4,5] pyrazino [2,1-b] [1,3] oxazine-6 , 8-dione | C18H17BrN2O4 | 405.243 | 60.77 | 2.3299 | ||||||||||
| 2, 5- Waikawa Pyridinedicarboxylic, 1- (2, 2- dimethoxyethyl) - 1, 4- dihydro- 3- methoxy- 4- oxo-, 2- methyl hākawa | C13H17NO8 | 315.276 | 113.29 | -0.0394 | ||||||||||
| (4R, 12aS) -N- (2,4-difluorobenzyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido [1 ' , 2 ': 4,5] pyrazino [2,1-b] [1,3] oxazine-9-motuka pouaka | (4R, 12aS) -N - [[2,4-bis (fluoranyl) phenyl] methyl] -7-methoxy-4-methyl-6,8-bis (oxidanylidene) -3,4,12,12a-tetrahydro- 2H-pyrido [5,6] pyrazino [2,6-b] [1,3] oxazine-9-carboxamide; | C21H21F2N3O5 | 433.405 | 89.87 | 1.9846 | |||||||||
| (4R, 12aS) -N- (2,4-difluorobenzyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido [1 ' , 2 ': 4,5] pyrazino [2,1-b] [1,3] oxazine-9-motuka pouaka | (4R, 12aS) -N - [[2,4-bis (fluoranyl) phenyl] methyl] -7-methoxy-4-methyl-6,8-bis (oxidanylidene) -3,4,12,12a-tetrahydro- 2H-pyrido [5,6] pyrazino [2,6-b] [1,3] oxazine-9-carboxamide; | C8H5ClF3NO.HCl | 433.405 | 89.87 | 1.9846 | |||||||||
| (S) -1- (2-Amino-5-chlorophenyl) -1- (trifluoromethyl) -3-cyclopropyl-2-propyn-1-ol | Efavirenz E pa ana ki te CoMpound A; | C13H11ClF3NO | 289.681 | 46.25 | 3.6667 | 1.46 | 425.052ºC i te 760 mmHg | 1.575 | 0mmHg i te 25 ° C | 2922199090 | ||||
| (1S) -1,5-anhydro-2,3,4,6-tetra-O-acteyl-1-C- [4-chloro-3 - [[4 - [[(3S) -tetrahydrofu-ran-3 -yl] oxy] phenyl] methyl] phenyl] -D-Glucitol | D-Glucitol, 1,5-anhydro-1-C- [4-chloro-3 - [[4 - [[(3S) -tetrahydro-3-furanyl] oxy] phenyl] methyl] phenyl] -, 2,3 , 4,6-tetraacetate, (1S) -; D-Glucitol, 1,5-anhydro-1-C- [4-chloro-3 - [[4 - [[(3S) -tetrahydro-3-furanyl] oxy ] phenyl] methyl] phenyl] -, tetraacetate, (1S) - (9CI); | C31H35ClO11 | 619.056 | 132.89 | 3.8966 | |||||||||
| (1S, 2R, 3S, 5R) -3-phenylmethoxy-2- (phenylmethoxymethyl) -6-oxabicyclo [3.1.0] hexane | (1S, 2R, 3S, 5R) -3- (Benzyloxy) -2 - ((benzyloxy) methyl) -6-oxabicyclo [3,1,0] hexane; (1S, 2R, 3S, 5R) -3- ( Phenylmethoxy) -2 - [(phenylmethoxy) methyl] -6-oxabicyclo [3.1.0] hexane; (2R, 3S) -benzyloxy-2-benzyloxymethyl-6-oxabicyclo <3.1.0> hexane; (1S, 2R, 3S , 5R) -3- (benzyloxy) -2- (benzyloxymethyl) -6-oxabicyclo [3.1.0] hexane; | C20H22O3 | 310.387 | 30.99 | 3.5759 | MFCD09750952 | 1.17 | 427.928ºC i te 760 mmHg | 145.852ºC | 1.593 | 0mmHg i te 25 ° C | 2932999099 | ||
| 2-amino-9 - ((1S, 3R, 4S) -4- (benzyloxy) -3- (benzyloxymethyl) -2-methylenecyclopentyl) -1H-purin-6 (9H)-kotahi | Entecavir InterMediate VIII IsoMer; 3 ', 5'-Di-O-benzyl Entecavir; Entecavir-9; Entecavir E8; Entecavir InterMediate N-1; | C26H27N5O3 | 457.524 | 108.05 | 4.2024 | 1.34 | 1.679 | |||||||
| 9 - [(1S, 3R, 4S) -2-methylidene-4-phenylmethoxy-3- (phenylmethoxymethyl) cyclopentyl] -6-phenylmethoxypurin-2-amine | 6- (Benzyloxy) -9 - [(1S, 3R, 4S) -2-methylene-4- (phenylmethoxy) -3 - [(phenylmethoxy) methyl] cyclopentyl] -9H-purine-2-amine; 6- (Benzyloxy ) -9 - ((1S, 3R, 4S) -4- (benzyloxy) -3 - ((benzyloxy) methyl) -2-methylenecyclopentyl) -9H-purin-2-amine; 9 - [(1S, 3R, 4S ) -2-Methylene-4- (phenylmethoxy) -3 - [(phenylmethoxy) methyl] cyclopentyl] -6- (phenylmethoxy) -9H-Purin-2-amine; | C33H33N5O3 | 533.62 | 97.31 | 6.2405 | 1.26 | 750.8ºC i te 760 mmHg | 407.8ºC | 1.653 | |||||
| 4-methylsulfanylbenzaldehyde | 4- (Methylthio) benzaldehyde; 4-Methylmercaptobenzaldehyde; | C8H8OS | 152.214 | 42.37 | 2.221 | MFCD00006948 | Wai kowhai | 1.144 | 86-90ºC (1 mmHg) | 6ºC | 6ºC | 1.646 | 29309070 | |
| 3,5-Dimethyl-4-hydroxybenzonitrile | 4-hydroxy-3,5-dimethylbenzonitrile; 4-Cyano-2,6-dimethylphenol; 2,6-Dimethyl-4-cyanophenol; | C9H9NO | 147.174 | 44.02 | 1.88068 | MFCD00221716 | He kikorangi parauri maama. | 1.13 g / cm3 | 310.6ºC i te 760 mmHg | 123-125ºC | 141.7ºC | 1.563 | 2926909090 | |
| Ethyl 2- (4-hydroxyphenyl) -4-methylthiazole-5-carboxylate | ethyl 4-methyl-2- (4-oxocyclohexa-2,5-dien-1-ylidene) -3H-1,3-thiazole-5-carboxylate; | C13H13NO3S | 263.312 | 87.66 | 3.0008 | MFCD03700424 | 1.274 | 426.819ºC i te 760 mmHg | 180ºC | 211.933ºC | 1.598 | 0mmHg i te 25 ° C | 2934100090 | |
| ethyl 2- (3-formyl-4-hydroxyphenyl) -4-methyl thiazole-5-carboxylate |
| mo te API | CAS KORE. | Ingoa hua | Ingoakapa | Tātai rāpoi | Taumaha Molecular | PSA | Takiuru | Tau MDL | Te Ahua me te Whenua Tinana | Taumaha | Tohu Whewhe | Tohu rewa | Tohu Hiko | Tohu Whakaoho | Te Pakaranga Ngawha | HS Waehere |
| Aceclofenac | 139272-68-7 | 2- (tert-butoxy) -2-oxoethyl 2- (2 - ((2,6-dichlorophenyl) amino) phenyl) acetate | ACECLOFENAC TERT-BUTYL ESTER; Aceclofenac Tert-Butyl Ester; | C20H21Cl2NO4 | 410.291 | 64.63 | 5.2374 | |||||||||
| Adapalene | 33626-98-1 | methyl 6-bromonaphthalene-2-carboxylate | 6-Bromo-2-naphthalenecarboxylic Acid Methyl Ester; methyl 6-bromo-2-naphthoate; methyl 6-bromo-2-naphthalenecarboxylate; 6-bromonaphthalene-2-carboxylic acid methyl ester; 6-bromo-2-naphthoic acid methyl ester ; methyl-6-bromonaphtoate; | C12H9BrO2 | 265.103 | 26.3 | 3.3889 | MFCD00100408 | Paura Koura Koura | 1.492 g / cm3 | 357ºC i te 760 mmHg | 123-126ºC | 169.7ºC | 1.634 | 2916399090 | |
| 104224-63-7 | 2- (1-Adamantyl) -4-bromoanisole | 1- (5-bromo-2-methoxyphenyl) adamantane; 1- (5-Bromo-2-methoxy-phenyl) adamantane; | C17H21BrO | 321.252 | 9.23 | 4.9255 | MFCD03855308 | 1.346g / cm3 | 402.5ºC i te 760mmHg | 160.3ºC | 1.593 | 2.54E-06mmHg i te 25 ° C | 2909309090 | |||
| Aprepitant | 155742-64-6 | Methyl 2- (2-chloro-1-iminoethyl) hydrazinecarboxylate | N-Methylcarbonyl-2-chloroacetamidrazone; | C4H8ClN3O2 | 165.578 | 74.21 | 0.9446 | MFCD09840880 | 2928000090 | |||||||
| 171482-05-6 | (2R, 3S) -2 - ((R) -1- (3,5-Bis (trifluoromethyl) phenyl) ethoxy) -3- (4-fluorophenyl) morpholine hydrochloride | (2R, 3S) -2 - ((R) -1- (3,5-Bis (trifluoromethyl) phenyl) ethoxy) -3- (4-fluorophenyl) morpholine hydrochloride | C20H18F7NO2.HCl | 473.812 | 30.49 | 6.7589 | 387.9ºC i te 760 mmHg | 188.4ºC | ||||||||
| Aripiprazole | 119532-26-2 | 1- (2,3-Dichlorophenyl) piperazine hydrochloride | RARECHEM AH CK 0082; 1- (2,3-Dichlorophenyl) piperazine Hydrochloride; DCPP-Hydrochloride; | C10H12Cl2N2.HCl | 267.583 | 15.27 | 3.5988 | MFCD00190238 | Tuatea-Maama | 1.272g / cm3 | 365.1ºC i te 760mmHg | 245-247ºC | 208.2ºC | 1.77E-07mmHg i te 25 ° C | 2933599090 | |
| 129722-34-5 | 3,4-Dihydro-7- (4-bromobutoxy) -2 (1H) -quinolinone | 7- (4-BroMobutoxy) -3,4-dihydro-2 (1H) -quinolinone; 7- (4-Bromobutoxy) -1,2,3,4-tetrahydro-2-oxoquinoline; 7- (4-bromobutoxy) -3,4-dihydro-1H-quinolin-2-one; 7- (4-Bromobutoxy) -3,4-dihydroquinolin-2 (1H)-kotahi; |
C13H16BrNO2 | 298.176 | 38.33 | 3.2632 | MFCD06658540 | 1.383 g / cm3 | 463.4ºC i te 760 mmHg | 110-111ºC | 234.1ºC | 1.573 | 2.45E-08mmHg i te 25 ° C | 2942000000 | ||
| 22246-18-0 | 7-hydroxy-3,4-dihydro-1H-quinolin-2-one | 3,4-Dihydro-7-hydroxycarbostyril; 7-Hydroxy-3,4-dihydroquinolin-2 (1H) -one; 7-Hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline; 7-Hydroxy-3 , 4-dihydro-2 (1H) -quinolinone; 7-Hydroxy-3,4-dihydro-quinolin-2-one; 7-hydroxy-3,4-dihydro-2-quinolinone; 7-Hydroxy-3,4- dihydro carbostyril; 3,4-Dihydro-7-hydroxy-2 (1H) -quinolinone; | C9H9NO2 | 163.173 | 49.33 | 1.4149 | MFCD06410891 | Paura ma | 1.282 g / cm3 | 403.7ºC i te 760 mmHg | 233-237ºC | 198ºC | 2933499090 | |||
| Atorvastatin | 125971-95-1 | tert-Butyl (4R, 6R) -2 - [[[6- (2-4-fluorophenyl) -5-isopropyl-3-phenyl-4- (phenylcarbamoyl) pyrrol-1-yl] ethyl] -2,2- dimethyl-1,3-dioxan-4-yl] acetate | Atorvastatin Acetonide tert-Butyl Ester; Atorvastatin takawaenga L1; Atorvastatin calciuM interMediate; | C40H47FN2O5 | 654.81 | 78.79 | 9.442 | 1.15 g / cm3 | 678.035ºC i te 760 mmHg | 144-148ºC | 363.863ºC | 1.589 | 0mmHg i te 25 ° C | |||
| Azathioprine | 50-44-2 | merc laptopurine | 1H-Purine-6 (9H) -thione; 6-Merc Laptopurine; 6H-Purine-6-thione, 1,7-dihydro-; 1,9-Dihydropurine-6-thione KAUPAPA, tirohia M225450; | C5H4N4S | 152.177 | 89.45 | 1.0155 | puehu karaehe kowhai | 1.82g / cm3 | > 313ºC | 255.4ºC | 1.828 | 2933599090 | |||
| 4897-25-0 | 5-Chloro-1-methyl-4-nitroimidazole | 5-Chloro-1-Methyl-4-Nitroimidazole; PCMNI; 1-methyl-4-nitro-5-chloroimidazole; 5-chloro-1-methyl-4-nitro-imidazole; 5-Chloro-1-methyl-4- nitro-1H-imidazole; 1-Methyl-5-chloro-4-nitroimidazole; Imidazole, 5-chloro-1-methyl-4-nitro; EINECS 225-521-2; 1H-Imidazole, 5-chloro-1-methyl -4-nitro; | C4H4ClN3O2 | 161.546 | 63.64 | 1.5049 | MFCD00233664 | Maamaa | 1.65 g / cm3 | 362.3ºC i te 760 mmHg | 146-150ºC | 172.9ºC | 1.648 | 2933290090 | ||
| Azithromycin | 76801-85-9 | Azathramycin | 9-deokso-9a-aza-9a-homoeritromicin A; Desmethylazithromycin; 9a-N-desmethyl azithromycin; DD-Azaerythromycin A; 10-Dihydro-10-deoxo-11-azaerythromycin A; 9-Deoxo-9a-aza-9a- homo Erythromycin A (Desmethyl Azithromycin); 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin A; 9a-aza-9-deoxo-9a-homoerythromycin A; 9-deoxo-9a-aza-9a-homoerythromycin Azaerythromycin A; UNII-4LSP9FJT5B; 9-deoxo-9a-aza-9a-homoerythromycin A; Azathramycin; | C37H70N2O12 | 734.958 | 188.87 | 1.8873 | Maamaa | 1.18 | 815.2ºC i te 760 mmHg | 126-136ºC | 446.8ºC | 1.536 | |||
| Bosentan | 138588-40-6 | 2-Amidinopyrimidine Hydrochloride | 2-Amidinopyrimidine hydrochloride; pyrimidine-2-carboximidamide, hydrochloride; | C5H6N4.HCl | 158.589 | 158.589 | 1.3627 | MFCD02677965 | puehu ma-ma | 1.39 g / cm3 | 287.4ºC i te 760 mmHg | 180-183ºC (Tuwhena) | 127.6ºC | 1.68 | 0.002mmHg i te 25 ° C | 2933599090 |
| 150728-12-4 | 5- (2-Methoxyphenoxy) - [2,2-Bipyrimidine] -4,6 (1H, 5H) -Dione | 5- (2-Methoxyphenoxy) - [2,2'-bipyrimidine] -4,6 (1H, 5H) -dione; 5- (2-Methoxyphenoxy) - [2,2'-bipyrimidine] -4,6 [1H , 5H] -mioni; | C15H12N4O4 | 312.28 | 102.77 | 0.1002 | MFCD09879703 | 1.45 | 1.676 | 2933599090 | ||||||
| 150728-13-5 | 4,6-Dichloro-5- (2-Methoxyphenoxy) -2,2-Bipyrimidine | 4,6-Dichloro-5- (2-methoxyphenoxy) -2,2'-bipyrimidine; 4,6-Dichloro-5- (2-methoxyphenoxy) -2,2'-bipyrimidine; 4,6-Dichloro-5- (O-methoxyphenoxy) -2- (2-pyrimidinyl) pyrimidine; 4,6-Dichloro-5- (2-methoxyphenoxy) -2,2-bipyrimidine; | C15H10Cl2N4O2 | 349.172 | 70.02 | 4.0413 | MFCD03839838 | Parauri totoka | 1.418 g / cm3 | 520.7ºC i te 760 mmHg | 268.7ºC | 1.617 | 0mmHg i te 25 ° C | 2933599090 | ||
| Capecitabine | 161599-46-8 | 2 ', 3'-di-O-acetyl-5'-deoxy-5-fluorocytidine | 5'-Deoxy-2 ', 3'-di-O-acetyl-5-fluorocytidine; [(2R, 3R, 4R, 5R) -4-acetyloxy-5- (4-amino-5-fluoro-2-oxopyrimidin -1-yl) -2-methyloxolan-3-yl] acetate; 2,3-Di-O-Acetyl-5-Deoxy-5-Fuluro-D-Cytidine; 2 ', 3'-di-O-acetyl- 5'-deoxy-5-fulurocytidine; | C13H16FN3O6 | 329.281 | 122.74 | 0.3265 | MFCD07369302 | 2934999090 | |||||||
| 62211-93-2 | 1,2,3-Triacetyl-5-deoxy-D-ribose | 1,2,3-Triacetyl-5-de; 1,2,3-triacetoxy-5-deoxy-D-ribose; Capecitabine takawaenga; 5-Deoxy-bD-ribofuranose triacetate; ACETYLFURANOSIDE; 5-Deoxy-bD-ribofuranose; 1,2,3-Triacetoxy-5-Deoxy Ribose; | C11H16O7 | 260.241 | 88.13 | 0.1577 | MFCD11519026 | 1.23 | 315ºC | 63-64ºC | 136ºC | 1.465 | 2940000000 | |||
| Cinacalcet | 134002-26-9 | (S) -2,2-Diphenyl-2- (pyrrolidin-3-yl) acetamide (2R, 3R) -2,3-dihydroxysuccinate | (2R, 3R) -2,3-dihydroxybutanedioic waikawa, 2,2-diphenyl-2 - [(3S) -pyrrolidin-3-yl] acetamide; | C18H20N2O.C4H6O6 | 430.451 | 170.18 | 0.974 | Paura ma | ||||||||
| 21172-41-8 | 3- [3- (trifluoromethyl) phenyl] whakatipuranga | 3- (3-Trifluoromethylphenyl) propionaldehyde | C10H9F3O | 202.173 | 17.07 | 2.8369 | te hinu karakara | 1.192 g / cm3 | 207.4ºC i te 760 mmHg | 93.1ºC | 2913000090 | |||||
| Koprofloxacin | 86393-33-1 | 7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid | 7-chloro-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid; | C13H9ClFNO3 | 281.667 | 59.3 | 2.8271 | MFCD00792458 | puehu tioata ma-ma | 410ºC | 239-244ºC | 236.4ºC | 2933499090 | |||
| Clavulanate Potassium | 61177-45-5 | Clavulanate pāhare pāporo | Pāhare pāporo (Z) - (2R, 5R) -3- (2-hydroxyethylidene) -7-oxo-4-oxa-1-azabicyclo [3.2.0] heptane-2-carboxylate | C8H8KNO5 | 237.251 | 89.9 | -2.4924 | MFCD01710901 | Pale Kōwhai totoka | 545.8ºC i te 760 mmHg | > 160ºC | 283.9ºC | 2942000000 | |||
| Clopidogrel | 141109-18-4 | (+) METHYL α- (2-THIENYLETHYLAMINO) (2-CHLOROPHENYL) ACETATE HCL | Methyl 2- (2-chlorophenyl) -2 - ((2- (thiophen-2-yl) ethyl) aMino) acetate hydrochloride; METHYL A - [[2- (THIEN-2-YL) ETHYL] AMINO] -A- (2-CHLOROPHENYL) ACETATE HYDROCHLORIDE; | C15H17Cl2NO2S | 346.272 | 66.57 | 4.6408 | 444ºC i te 760 mmHg | 222.4ºC | 2.73E-08mmHg i te 25 ° C | ||||||
| Cobicistat | 154212-60-9 | N-methyl-1- (2-propan-2-yl-1,3-thiazol-4-yl) methanamine | 1- (2-Isopropylthiazol-4-yl) -N-methyl methanamine | C8H14N2S | 170.275 | 53.16 | 2.3768 | 1.039g / cm3 | 230.874ºC i te 760 mmHg | 93.429ºC | 1.523 | 0.064mmHg i te 25 ° C | 2934100090 | |||
| 1185167-55-8 | 1- (2-Isopropyl-1,3-thiazol-4-yl) -N-methylmethanamine dihydrochlor ide | N-Methyl-2- (1-methylethyl) -4-thiazolemethanamine dihydrochloride | C8H14N2S.2 (HCl) | 243.197 | 53.16 | 3.9808 | 2934100090 | |||||||||
| Darunavir | 169280-56-2 | 4-amino-N - [(2R, 3S) -3-amino-2-hydroxy-4-phenylbutyl] -N- (2-methylpropyl) benzenesulfonamide | C20H29N3O3S | 391.528 | 118.03 | 4.2087 | 1.226 g / cm3 | 609.105ºC i te 760 mmHg | 322.175ºC | 1.605 | ||||||
| 866594-60-7 | (3aS, 4S, 6aR) -4-methoxy-tetrahydro-furo [3.4-b] furan-2 (3H)-kotahi | (3aS, 4S, 6aR) -4-Methoxytetrahydrofuro [3,4-b] furan-2 (3H)-Kotahi; (3aS, 4S, 6aR) - 4-methoxytetrahydrofuro [3,4-b] furan-2 ( 3H) -one; FURO [3,4-B] FURAN-2 (3H) -ONE, TETRAHYDRO-4-METHOXY-, (3AS, 4S, 6AR) -; (3aS, 4S, 6aR) -Tetrahydro-4- methoxyfuro [3,4-b] furan-2 (3H)-kotahi; | C7H10O4 | 158.152 | 44.76 | -0.0792 | ||||||||||
| 253265-97-3 | [(3R, 3aS, 6aR) -Hydroxyhexahydrofuro [2,3-b] furanyl Succinimidyl Carbonate | (3R, 3aS, 6aR) -Hydroxyhexahydrofuro [2,3-β] furanyl Succinimidyl Carbonate; | C11H13NO7 | 271.223 | 91.37 | -0.0971 | 1.51 g / cm3 | 391.8ºC i te 760 mmHg | 190.7ºC | 1.562 | 2.41E-06mmHg i te 25 ° C | |||||
| Te Sodium Diclofenac | 15362-40-0 | 1- (2,6-Dichlorophenyl) Indolin-2-Kotahi | 1- (2,6-Dichlorophenyl) -1,3-dihydro-2H-indol-2-one; Diclofenac Amide; (N- (2,6-Dichlorophenyl) -2-indolinone; 1- (2,6-Dichlorophenyl ) indolin-2-one; 1- (2,6-Dichlorophenyl) -2-oxoindoline; 1- (2,6-Dichlorophenyl) -2-indolinone; 1- (2,6-Dichlorophenyl) oxindole; 1- (2 , 6-dichlorophenyl) -3H-indol-2-one; Diclofenac poke A; N- (2,6-Dichlorophenyl) -2-indolinone; | C14H9Cl2NO | 278.133 | 20.31 | 4.2792 | MFCD00451393 | 1.432 g / cm3 | 488.6ºC i te 760 mmHg | 249.3ºC | 2933790090 | ||||
| Dolutegravir | 61477-40-5 | (R) -3-Aminobutan-1-ol | (3R) -3-aminobutan-1-ol; | C4H11NO | 89.1362 | 46.25 | 0.4163 | 640-387-9 | 168.349ºC i te 760 mmHg | 55.616ºC | 2922199090 | |||||
| 1299006-34-1 | 2H-Pyrido [1 ', 2'; 4,5] pyrazino [2,1-b] [1,3] oxazine-6,8-dione, 3,4,12,12a-tetrahydro-7- (phenylmethoxy) | |||||||||||||||
| 1229006-35-2 | 7- (benzyloxy) -9-bromo-3,4,12,12a-tetrahydro-2H-pyrido [1 ', 2': 4,5] pyrazino [2,1-b] [1,3] oxazine-6 , 8-dione | C18H17BrN2O4 | 405.243 | 60.77 | 2.3299 | |||||||||||
| 1335210-23-5 | 2, 5- Waikawa Pyridinedicarboxylic, 1- (2, 2- dimethoxyethyl) - 1, 4- dihydro- 3- methoxy- 4- oxo-, 2- methyl hākawa | C13H17NO8 | 315.276 | 113.29 | -0.0394 | |||||||||||
| 1335210-35-9 | (4R, 12aS) -N- (2,4-difluorobenzyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido [1 ' , 2 ': 4,5] pyrazino [2,1-b] [1,3] oxazine-9-motuka pouaka | (4R, 12aS) -N - [[2,4-bis (fluoranyl) phenyl] methyl] -7-methoxy-4-methyl-6,8-bis (oxidanylidene) -3,4,12,12a-tetrahydro- 2H-pyrido [5,6] pyrazino [2,6-b] [1,3] oxazine-9-carboxamide; | C21H21F2N3O5 | 433.405 | 89.87 | 1.9846 | ||||||||||
| Efavirenz | 173676-59-0 | (4R, 12aS) -N- (2,4-difluorobenzyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido [1 ' , 2 ': 4,5] pyrazino [2,1-b] [1,3] oxazine-9-motuka pouaka | (4R, 12aS) -N - [[2,4-bis (fluoranyl) phenyl] methyl] -7-methoxy-4-methyl-6,8-bis (oxidanylidene) -3,4,12,12a-tetrahydro- 2H-pyrido [5,6] pyrazino [2,6-b] [1,3] oxazine-9-carboxamide; | C8H5ClF3NO.HCl | 433.405 | 89.87 | 1.9846 | |||||||||
| 209414-27-7 | (S) -1- (2-Amino-5-chlorophenyl) -1- (trifluoromethyl) -3-cyclopropyl-2-propyn-1-ol | Efavirenz E pa ana ki te CoMpound A; | C13H11ClF3NO | 289.681 | 46.25 | 3.6667 | 1.46 | 425.052ºC i te 760 mmHg | 1.575 | 0mmHg i te 25 ° C | 2922199090 | |||||
| Empagliflozin | 915095-99-7 | (1S) -1,5-anhydro-2,3,4,6-tetra-O-acteyl-1-C- [4-chloro-3 - [[4 - [[(3S) -tetrahydrofu-ran-3 -yl] oxy] phenyl] methyl] phenyl] -D-Glucitol | D-Glucitol, 1,5-anhydro-1-C- [4-chloro-3 - [[4 - [[(3S) -tetrahydro-3-furanyl] oxy] phenyl] methyl] phenyl] -, 2,3 , 4,6-tetraacetate, (1S) -; D-Glucitol, 1,5-anhydro-1-C- [4-chloro-3 - [[4 - [[(3S) -tetrahydro-3-furanyl] oxy ] phenyl] methyl] phenyl] -, tetraacetate, (1S) - (9CI); | C31H35ClO11 | 619.056 | 132.89 | 3.8966 | |||||||||
| Entecavir | 110567-22-1 | (1S, 2R, 3S, 5R) -3-phenylmethoxy-2- (phenylmethoxymethyl) -6-oxabicyclo [3.1.0] hexane | (1S, 2R, 3S, 5R) -3- (Benzyloxy) -2 - ((benzyloxy) methyl) -6-oxabicyclo [3,1,0] hexane; (1S, 2R, 3S, 5R) -3- ( Phenylmethoxy) -2 - [(phenylmethoxy) methyl] -6-oxabicyclo [3.1.0] hexane; (2R, 3S) -benzyloxy-2-benzyloxymethyl-6-oxabicyclo <3.1.0> hexane; (1S, 2R, 3S , 5R) -3- (benzyloxy) -2- (benzyloxymethyl) -6-oxabicyclo [3.1.0] hexane; | C20H22O3 | 310.387 | 30.99 | 3.5759 | MFCD09750952 | 1.17 | 427.928ºC i te 760 mmHg | 145.852ºC | 1.593 | 0mmHg i te 25 ° C | 2932999099 | ||
| 142217-81-0 | 2-amino-9 - ((1S, 3R, 4S) -4- (benzyloxy) -3- (benzyloxymethyl) -2-methylenecyclopentyl) -1H-purin-6 (9H)-kotahi | Entecavir InterMediate VIII IsoMer; 3 ', 5'-Di-O-benzyl Entecavir; Entecavir-9; Entecavir E8; Entecavir InterMediate N-1; |
C26H27N5O3 | 457.524 | 108.05 | 4.2024 | 1.34 | 1.679 | ||||||||
| 204845-95-4 | 9 - [(1S, 3R, 4S) -2-methylidene-4-phenylmethoxy-3- (phenylmethoxymethyl) cyclopentyl] -6-phenylmethoxypurin-2-amine | 6- (Benzyloxy) -9 - [(1S, 3R, 4S) -2-methylene-4- (phenylmethoxy) -3 - [(phenylmethoxy) methyl] cyclopentyl] -9H-purine-2-amine; 6- (Benzyloxy ) -9 - ((1S, 3R, 4S) -4- (benzyloxy) -3 - ((benzyloxy) methyl) -2-methylenecyclopentyl) -9H-purin-2-amine; 9 - [(1S, 3R, 4S ) -2-Methylene-4- (phenylmethoxy) -3 - [(phenylmethoxy) methyl] cyclopentyl] -6- (phenylmethoxy) -9H-Purin-2-amine; | C33H33N5O3 | 533.62 | 97.31 | 6.2405 | 1.26 | 750.8ºC i te 760 mmHg | 407.8ºC | 1.653 | ||||||
| Etoricoxib | 3446-89-7 | 4-methylsulfanylbenzaldehyde | 4- (Methylthio) benzaldehyde; 4-Methylmercaptobenzaldehyde; | C8H8OS | 152.214 | 42.37 | 2.221 | MFCD00006948 | Wai kowhai | 1.144 | 86-90ºC (1 mmHg) | 6ºC | 6ºC | 1.646 | 29309070 | |
| Etravirinem | 4198-90-7 | 3,5-Dimethyl-4-hydroxybenzonitrile | 4-hydroxy-3,5-dimethylbenzonitrile; 4-Cyano-2,6-dimethylphenol; 2,6-Dimethyl-4-cyanophenol; | C9H9NO | 147.174 | 44.02 | 1.88068 | MFCD00221716 | He kikorangi parauri maama. | 1.13 g / cm3 | 310.6ºC i te 760 mmHg | 123-125ºC | 141.7ºC | 1.563 | 2926909090 | |
| Febuxostat | 161797-99-5 | Ethyl 2- (4-hydroxyphenyl) -4-methylthiazole-5-carboxylate | ethyl 4-methyl-2- (4-oxocyclohexa-2,5-dien-1-ylidene) -3H-1,3-thiazole-5-carboxylate; | C13H13NO3S | 263.312 | 87.66 | 3.0008 | MFCD03700424 | 1.274 | 426.819ºC i te 760 mmHg | 180ºC | 211.933ºC | 1.598 | 0mmHg i te 25 ° C | 2934100090 | |
| ethyl 2- (3-formyl-4-hydroxyphenyl) -4-methyl thiazole-5-carboxylate |
Tuhia to korero ki konei ka tuku mai ki a maatau
